跳至主要内容

Bortezomib-Induced Multiple Chalazia: A Case Report

Read  full  paper  at:
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=53324#.VL3BYCzQrzE

ABSTRACT
Bortezomib is a novel agent for the treatment of patients with multiple myeloma. Several cutaneous lesions have been associated with its use and chalazia have been reported in a few cases with a delayed appearance ranging from 1 to 6 months. We describe the case of a 59-year-old man with multiple myeloma IgG kappa, ISS2, who developed a chalazion induced by bortezomib. Following the failure of conservative treatment, a biopsy was performed to exclude extramedullary plasmocytoma. Bortezomib was discontinued due to the persistence of lesions and a therapeutic approach combining systemic antibiotics with incision and curettage was adopted. An active inflammatory lesion developed after 1 month, similar to that observed under bortezomib therapy. Symptoms resolved only 5 months later and the patient remained free of any ocular manifestation. Physicians should be aware that chalazia may be resistant to conventional treatment and lead to local complications, such as cellulitis.
 
Cite this paper
Mohamed, R. , Massa, H. , Schwarz, C. , Grandjean-Hallez, N. and Samii, K. (2015) Bortezomib-Induced Multiple Chalazia: A Case Report. Case Reports in Clinical Medicine, 4, 32-35. doi: 10.4236/crcm.2015.41008.
 
References
[1]Wojtowicz, J.C., Butovich, I.A., McMahon, A., Hogan, R.N., Itani, K.M., Mancini, R., Molai, M. and Linsenbardt, E. (2014) Time-Dependent Degenerative Transformations in the Lipidome of Chalazia. Experimental Eye Research, 127, 261-269. http://dx.doi.org/10.1016/j.exer.2014.08.008
 
[2]Mateos, M.V., Hernandez, J.M., Hernandez, M.T., Gutierrez, N.C., Palomera, L., Fuertes, M., Garcia-Sanchez, P., Lahuerta, J.J., de la Rubia, J., Terol, M.J., Sureda, A., Bargay, J., Ribas, P., Alegre, A., de Arriba, F., Oriol, A., Carrera, D., Garcia-Larana, J., Garcia-Sanz, R., Blade, J., Prosper, F., Mateo, G., Esseltine, D.L., van de Velde, H. and San Miguel, J.F. (2008) Bortezomib plus Melphalan and Prednisone in Elderly Untreated Patients with Multiple Myeloma: Updated Time-to-Events Results and Prognostic Factors for Time to Progression. Haematologica, 93, 560-565.
http://dx.doi.org/10.3324/haematol.12106
 
[3]Mateos, M.V., Hernandez, J.M., Hernandez, M.T., Gutierrez, N.C., Palomera, L., Fuertes, M., Diaz-Mediavilla, J., Lahuerta, J.J., de la Rubia, J., Terol, M.J., Sureda, A., Bargay, J., Ribas, P., de Arriba, F., Alegre, A., Oriol, A., Carrera, D., Garcia-Larana, J., Garcia-Sanz, R., Blade, J., Prosper, F., Mateo, G., Esseltine, D.L., van de Velde, H. and San Miguel, J.F. (2006) Bortezomib plus Melphalan and Prednisone in Elderly Untreated Patients with Multiple Myeloma: Results of a Multicenter Phase 1/2 Study. Blood, 108, 2165-2172. http://dx.doi.org/10.1182/blood-2006-04-019778
 
[4]Richardson, P.G., Barlogie, B., Berenson, J., Singhal, S., Jagannath, S., Irwin, D., Rajkumar, S.V., Srkalovic, G., Alsina, M., Alexanian, R., Siegel, D., Orlowski, R.Z., Kuter, D., Limentani, S.A., Lee, S., Hideshima, T., Esseltine, D.L., Kauffman, M., Adams, J., Schenkein, D.P. and Anderson, K.C. (2003) A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma. New England Journal of Medicine, 348, 2609-2617.
http://dx.doi.org/10.1056/NEJMoa030288
 
[5]Richardson, P.G., Briemberg, H., Jagannath, S., Wen, P.Y., Barlogie, B., Berenson, J., Singhal, S., Siegel, D.S., Irwin, D., Schuster, M., Srkalovic, G., Alexanian, R., Rajkumar, S.V., Limentani, S., Alsina, M., Orlowski, R.Z., Najarian, K., Esseltine, D., Anderson, K.C. and Amato, A.A. (2006) Frequency, Characteristics, and Reversibility of Peripheral Neuropathy during Treatment of Advanced Multiple Myeloma with Bortezomib. Journal of Clinical Oncology, 24, 3113-3120.
http://dx.doi.org/10.1200/JCO.2005.04.7779
 
[6]Agterof, M.J. and Biesma, D.H. (2005) Images in Clinical Medicine. Bortezomib-Induced Skin Lesions. New England Journal of Medicine, 352, 2534. http://dx.doi.org/10.1056/NEJMicm041166
 
[7]Pour, L., Hajek, R., Zdenek, A., Krejci, M., Krivanova, A. and Vorlicek, J. (2005) Skin Lesions Induced by Bortezomib. Haematologica, 90, ECR44.
 
[8]Min, C.K., Lee, S., Kim, Y.J., Eom, K.S., Lee, J.W., Min, W.S., Kim, C.C., Cho, C.S. and Park, G. (2006) Cutaneous Leucoclastic Vasculitis (LV) Following Bortezomib Therapy in a Myeloma Patient; Association with Pro-Inflammatory Cytokines. European Journal of Haematology, 76, 265-268.
http://dx.doi.org/10.1111/j.0902-4441.2005.t01-1-EJH2437.x
 
[9]Truchuelo, M., Bagazgoitia, L., Alcantara, J., Velasco, D. and Carrillo, R. (2012) Sweet-Like Lesions Induced by Bortezomib: A Review of the Literature and a Report of 2 Cases. Actas Dermo-Sifiliograficas, 103, 829-831.
http://dx.doi.org/10.1016/j.ad.2012.03.002
 
[10]Wu, K.L., Heule, F., Lam, K. and Sonneveld, P. (2006) Pleomorphic Presentation of Cutaneous Lesions Associated with the Proteasome Inhibitor Bortezomib in Patients with Multiple Myeloma. Journal of the American Academy of Dermatology, 55, 897-900. http://dx.doi.org/10.1016/j.jaad.2006.06.030
 
[11]Patrizi, A., Venturi, M., Dika, E., Maibach, H., Tacchetti, P. and Brandi, G. (2014) Cutaneous Adverse Reactions Linked to Targeted Anticancer Therapies Bortezomib and Lenalidomide for Multiple Myeloma: New Drugs, Old Side Effects. Cutaneous and Ocular Toxicology, 33, 1-6.
http://dx.doi.org/10.3109/15569527.2013.787086
 
[12]Grob, S.R., Jakobiec, F.A., Rashid, A. and Yoon, M.K. (2014) Chalazia Associated with Bortezomib Therapy for Multiple Myeloma. Ophthalmology, 121, 1845-1847. http://dx.doi.org/10.1016/j.ophtha.2014.04.021
 
[13]Zhang, K., Wang, S., Malhotra, J., Hassler, J.R., Back, S.H., Wang, G., Chang, L., Xu, W., Miao, H., Leonardi, R., Chen, Y.E., Jackowski, S. and Kaufman, R.J. (2011) The Unfolded Protein Response Transducer IRE1 Alpha Prevents ER Stress-Induced Hepatic Steatosis. EMBO Journal, 30, 1357-1375. http://dx.doi.org/10.1038/emboj.2011.52                                                                                                       eww150120lx
标签：

评论

发表评论

此博客中的热门博文

Does Immigration Promote the Investment of the Monopolistic Firm?

In the present paper, we examine the effect of increasing uncertainty of immigrants’ growth on the optimal timing of investment of a firm that has a monopolistic power over the labor market. It is revealed that when the uncertainty of immigrants’ growth is more than a threshold level, increasing uncertainty of immigrants’ growth accelerates the optimal timing of firms’ investment and enhances the economic growth, even if the uncertainty of immigrants’ growth is formulated by the geometric Brownian motion, which is in sharp contrast to the standard result that an increase in the uncertainty postpones the optimal timing. With an increase in the immigrants over the past ten years, workforces in the host countries have been growing significantly to the extent that the immigrants represent 70% of the increase in the workforce in Europe, and 47% in the United States as OECD indicates. In the present paper, we attempted to investigate the effect of increased uncertainty caused by the growi...
发表评论
阅读全文

Education Policy Implementation: A Mechanism for Enhancing Primary Education Development in Zanzibar

Education is one of the fundamental rights of individuals; therefore, the government of a country needs to develop and strengthen educational policy and quality as well as to ensure that everyone has equal access to basic education. The improvement of access and quality of education in the world is becoming as an essential factor in development, whereas the basic education (primary school), is acknowledged as a foundation of the higher educational development for every country. To fulfill this goal, governments introduce several policies and procedures; however, it requires some reforms and participation from the politician, policymakers, and other stakeholders to re-examine educational policy so that it can lead to multiplication and betterment of the reforms. Educational reforms actually focus on accountability. A positive educational development and reform is very challenging and needs more effort and strategy on how to use and utilize the resources effectively as such it can achie...
发表评论
阅读全文